Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Pr… (NCT06701032) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation Program
Canada80 participantsStarted 2024-11-25
Plain-language summary
The main purpose of this study is to evaluate the hemodynamic changes in the forefoot of patients with coronary, cerebrovascular or peripheral atherosclerotic disease referred a 12-week cardiovascular rehabilitation program (PREV program).
Also, this study will describe the characteristics of patients admitted to the PREV program and their evolutions in terms of favorable, unfavorable outcomes and complications and up to one year after completion of the program.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Any individual aged 18 years and older who has been diagnosed with peripheral artery disease, coronary artery disease, angina, ischemic heart failure, transient ischemic attack or ischemic stroke (non-cardioembolic, non-hemorrhagic);
* Have been admitted to the PREV program;
Exclusion Criteria:
* Being not able to give written informed consent;
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study is measuring things like toe pressure and ankle-brachial index — can you explain what those numbers mean for my specific condition, whether it's PAD, CAD, or cerebrovascular disease, and why tracking them matters for my care?
2Since this trial is listed as 'active, not recruiting,' does that mean I can no longer join, and if so, are there similar cardiovascular rehabilitation studies I might still be eligible for?
3The trial involves a secondary prevention and cardiovascular rehabilitation program — is that kind of rehab program something you'd recommend for me right now, regardless of this study, and what would it actually involve day-to-day?
4This trial has no assigned phase, which suggests it's more of an observational study than a treatment trial — does that mean there's no experimental therapy involved, and what would participating have looked like compared to my current treatment plan?
5Given that this study tracks changes in blood flow measurements over time in people with atherosclerotic disease, what do my own current ankle-brachial or toe-brachial numbers look like, and what trends should we be watching for as part of my ongoing monitoring?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.